| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |